Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Dawn Svoronos to be replaced by Frank Holler (MPC)
View:
Post by Saurus100 on Apr 15, 2024 10:29am

Dawn Svoronos to be replaced by Frank Holler (MPC)

In the Management Proxy Circular (page 9) "The Board has agreed that Mr. Frank Holler, a current director and the current Chair of the Audit Committee, would be appointed as Chair of the Board in replacement of Ms. Dawn Svoronos after the Meeting if he is elected as a director of the Corporation"
Comment by Trogarzon on Apr 15, 2024 10:35am
Indeed... hope it meens her CEO pick goes the same way....
Comment by Trogarzon on Apr 15, 2024 10:46am
At least he comes from an entrepreneurial background unlike our big pharma floaters or Chair and CEO.... 
Comment by Lee430 on Apr 15, 2024 1:42pm
Well, it looks like I will now be voting for Holler, Zwick & Tea, and Nay to the rest of the BOD…Why would anyone vote for Dawn who oversaw the destruction of our Thera? and then we have Weil, another Dawn appointee who oversaw Tetra’s company bankruptcy! While I am on a roll can anyone explain to me what the heck did Molson (Another Dawn appointee) bring to the table other than that silver ...more  
Comment by Trogarzon on Apr 15, 2024 1:52pm
Nobody cared to expain to us the merits of choosing Holler apart from the convenience of it.  He also oversaw the destruction of the company.  Also why vote for Mme Tea who was parachuted from IQ tahmks to our givaway bonanza of last october.  October fest I call it since they celebrated on Linked in.  I'm voting all out except Zwick whom I strongly thing is there because ...more  
Comment by Trogarzon on Apr 15, 2024 2:34pm
I hope they merge with a cash rich company and change the name.
Comment by SPCEO1 on Apr 15, 2024 2:53pm
I would point out that Holler was Chair of the short-lived "Financing Committee" that brought us the IQ deal. That might affect your opinion of him.
Comment by Trogarzon on Apr 15, 2024 3:03pm
So you are saying this guy promoted the IQ deal and will probably throw us under the bus again.  .
Comment by Lee430 on Apr 15, 2024 3:19pm
Thanks SPCEO as I was not aware of that and will definitely be recanting my support for him.
Comment by Mannequin on Apr 15, 2024 3:40pm
And how will you vote this year Rusty?
Comment by SPCEO1 on Apr 15, 2024 5:26pm
Lots to consider before we vote our shares. Much depends on what Soleus and other large shareholders do. So, I have not decided and likely will not decide until the last minute. Last year's experience clearly resulted in a far less ideal outcome than we all hoped so it would be hard for that experience not to have an impact on this year's vote. But, if other large shareholders vote for the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities